These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 793113)

  • 1. Preceding transfusions and marrow graft rejection in dogs and man.
    Weiden PL; Storb R; Thomas ED; Graham TC; Lerner KG; Buckner CD; Fefer A; Neiman PE; Clift RA
    Transplant Proc; 1976 Dec; 8(4):551-4. PubMed ID: 793113
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
    Smith BR; Guinan EC; Parkman R; Ferrara J; Levey RH; Nathan DG; Rappeport JM
    Transplantation; 1985 Jun; 39(6):671-3. PubMed ID: 3890295
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful bone marrow transplantation in sensitized recipients.
    Levey RH; Parkman R; Rappeport J; Nathan DG; Rosen F
    Transplant Proc; 1979 Mar; 11(1):199-204. PubMed ID: 377631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract]   [Full Text] [Related]  

  • 5. Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle.
    Storb R; Thomas ED; Weiden PL; Buckner CD; Clift RA; Fefer A; Fernando LP; Giblett ER; Goodell BW; Johnson FL; Lerner KG; Neiman PE; Sanders JE
    Blood; 1976 Dec; 48(6):817-41. PubMed ID: 11859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin--long-term results.
    Mathé G; Schwarzenberg L
    Transplant Proc; 1976 Dec; 8(4):595-602. PubMed ID: 136773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic marrow transplantation using matched sibling donors.
    Thomas ED
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):115-9. PubMed ID: 4155158
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation.
    Santos GW
    Adv Intern Med; 1979; 24():157-82. PubMed ID: 34319
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic and hematologic concepts in marrow transplantation as they relate to aplastic anemia.
    Storb R
    Transplant Proc; 1979 Dec; 11(4):1916-9. PubMed ID: 43611
    [No Abstract]   [Full Text] [Related]  

  • 10. Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
    Oldham RK; Simmler MC
    Transplant Proc; 1974 Dec; 6(4):417-9. PubMed ID: 4280166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].
    Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM
    Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811
    [No Abstract]   [Full Text] [Related]  

  • 12. Marrow transplantation for nonmalignant disorders.
    Thomas ED
    N Engl J Med; 1978 Apr; 298(17):963-4. PubMed ID: 417247
    [No Abstract]   [Full Text] [Related]  

  • 13. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 14. Marrow transplants in aplastic anemia and leukemia.
    Fefer A; Thomas ED; Buckner CD; Storb R; Neiman P; Glucksberg H; Clift RA; Lerner KG
    Semin Hematol; 1974 Jul; 11(3):353-67. PubMed ID: 4151983
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.
    Speck B; Buckner CD; Cornu P; Jeannet B
    Transplant Proc; 1976 Dec; 8(4):617-22. PubMed ID: 11593
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
    Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
    J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human marrow transplantation--current status.
    Buckner CD; Clift RA; Fefer A; Neiman P; Storb R; Thomas ED
    Prog Hematol; 1973; 8():299-324. PubMed ID: 4150971
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone marrow transplantation for aplastic anemia.
    Ramsay NK; Storb R
    Prog Clin Biol Res; 1984; 148():291-5. PubMed ID: 6379666
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful retransplantation of bone marrow following failure of initial engraftment in a patient with aplastic anemia.
    Meuwissen HJ; Moore EC; Strauss HS; Taft E; Britten A
    J Pediatr; 1976 Oct; 89(4):588-92. PubMed ID: 784930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.